Nucleic Acids Research, 1988, Vol. 16, No. 18 8789-8802
© 1988
Articles |
Human liver-type arginase gene: structure of the gene and analysis of the promoter region
1Institute for Medical Genetics, Kumamoto University Medical School Kumamoto 862, Japan 2Department of Pediatrics, Kumamoto University Medical School Kumamoto 862, Japan
*To whom correspondence should be addressed
Received July 11, 1988. Revised August 23, 1988. Accepted August 23, 1988.
The gene for human liver-type arginase (EC 3.5.3.1 [EC] ), a urea cycle enzyme, was cloned and the structure was determined. This gene is 11.5 kilobases long and is split into 8 exons. The cap site was determined by nuclease S1 mapping and primer extension. A "TATA box"-like sequence is located 28 bases upstream from the cap site, and a sequence similar to the binding sites of the transcription factor CTF/NF1, a "CAAT box"-binding protein, is located 72 bases upstream. In the 5' end region, sequences resembling the glucocorticoid responsive elements, the cAMP responsive elements, and the enhancer core sequences are present. The immediately 5' flanking region of the human gene up to position –105 is 84% identical with the corresponding segment of the rat gene. In this region of the human gene, one DNase I-protected area and several hypersensitive cleavage sites were detected by footprint analysis, using nuclear extracts from the rat liver. The protected area contains the sequence similar to the binding sites of CTF/NF1 and also overlaps with the sequence resembling the glucocorticoid responsive elements.
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  M. Mori Regulation of Nitric Oxide Synthesis and Apoptosis by Arginase and Arginine Recycling J. Nutr., June 1, 2007; 137(6): 1616S - 1620S. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. R. Almon, D. C. DuBois, and W. J. Jusko A Microarray Analysis of the Temporal Response of Liver to Methylprednisolone: A Comparative Analysis of Two Dosing Regimens Endocrinology, May 1, 2007; 148(5): 2209 - 2225. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A.-L. Pauleau, R. Rutschman, R. Lang, A. Pernis, S. S. Watowich, and P. J. Murray Enhancer-Mediated Control of Macrophage-Specific Arginase I Expression J. Immunol., June 15, 2004; 172(12): 7565 - 7573. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. K. Iyer, P. K. Yoo, R. M. Kern, N. Rozengurt, R. Tsoa, W. E. O'Brien, H. Yu, W. W. Grody, and S. D. Cederbaum Mouse Model for Human Arginase Deficiency Mol. Cell. Biol., July 1, 2002; 22(13): 4491 - 4498. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C.-I Chang, B. Zoghi, J. C. Liao, and L. Kuo The Involvement of Tyrosine Kinases, Cyclic AMP/Protein Kinase A, and p38 Mitogen-Activated Protein Kinase in IL-13-Mediated Arginase I Induction in Macrophages: Its Implications in IL-13-Inhibited Nitric Oxide Production J. Immunol., August 15, 2000; 165(4): 2134 - 2141. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. H. Wei, A. T. Jacobs, S. M. Morris Jr., and L. J. Ignarro IL-4 and IL-13 upregulate arginase I expression by cAMP and JAK/STAT6 pathways in vascular smooth muscle cells Am J Physiol Cell Physiol, July 1, 2000; 279(1): C248 - C256. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Sonoki, A. Nagasaki, T. Gotoh, M. Takiguchi, M. Takeya, H. Matsuzaki, and M. Mori Coinduction of Nitric-oxide Synthase and Arginase I in Cultured Rat Peritoneal Macrophages and Rat Tissues in Vivo by Lipopolysaccharide J. Biol. Chem., February 7, 1997; 272(6): 3689 - 3693. [Abstract] [Full Text] [PDF]
|
|